FDA Asks Makers of Anti-Diarrhea Drug to Change Packaging to Curb Abuse

anti-diarrhea drug, Imodium, loperamide

The Food and Drug Administration (FDA) this week asked the makers of the over-the-counter anti-diarrhea drug loperamide (Imodium A-D) to change the way they package their products, in an effort to reduce abuse.

Some people take extremely high doses of loperamide in an attempt to manage opioid withdrawal symptoms or to achieve euphoric effects of opioid use, the FDA said in a statement.

Loperamide is safe when used at recommended doses, The Washington Post reports. But when it is taken at extremely high doses, the drug can cause dangerous, irregular heartbeats.

The FDA is asking manufacturers to redesign their packages so they contain only enough medication for short-term use. The agency is also asking for “unit dose packaging,” such as blister packs that require a person to unpeel each dose separately.

Get One-on-One Help to Address Your Child’s Substance Use

We have trained and caring master’s-level counselors ready to help any parent struggling with a child’s drug or alcohol use. They are here to listen, help you find answers and make an action plan. Call the Helpline, connect via live chat or email us to get help. All communications are free and confidential. Our services are made possible thanks to the generous support of donors.

Leave a Comment

Please leave a comment below to contribute to the discussion. If you have a specific question, please contact a Parent Specialist, who will provide you with one-on-one help.

Your email address will not be published. Required fields are marked *